These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1151 related items for PubMed ID: 28789622

  • 1. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G, Yu J, Song H, Zhu S, Sun L, Shang Z, Niu Y.
    BMC Cancer; 2017 Aug 08; 17(1):530. PubMed ID: 28789622
    [Abstract] [Full Text] [Related]

  • 2. Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer.
    Li G, Song H, Wang J, Bao Y, Niu Y.
    Sci Rep; 2016 Jun 09; 6():27586. PubMed ID: 27279531
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.
    J Urol; 2009 Jul 09; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [Abstract] [Full Text] [Related]

  • 4. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
    Ge P, Wang ZC, Yu X, Lin J, He Q.
    BMC Urol; 2015 May 30; 15():46. PubMed ID: 26025446
    [Abstract] [Full Text] [Related]

  • 5. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec 30; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 6. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, Boorjian SA.
    J Urol; 2012 Aug 30; 188(2):405-9. PubMed ID: 22704101
    [Abstract] [Full Text] [Related]

  • 7. Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis.
    Zhao G, Wang C, Tang Y, Liu X, Liu Z, Li G, Mei Y.
    Sci Rep; 2019 Mar 29; 9(1):5323. PubMed ID: 30926888
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic and clinicopathologic value of ki-67 and profilin 1 immunohistochemical expression in primary pT1 urothelial bladder cancer.
    Culpan M, Turan T, Ozkanli SS, Zenginkinet T, Kazan O, Ucar T, Atis G, Caskurlu T, Yildirim A.
    J Cancer Res Ther; 2021 Mar 29; 17(2):434-442. PubMed ID: 34121689
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S, Otto W, Denzinger S, Wieland WF, Burger M, Stöhr R, Link S, Hofstädter F, Hartmann A.
    Eur Urol; 2014 Jan 29; 65(1):218-26. PubMed ID: 22633802
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, Chung J, Lee KH.
    J Urol; 2009 Dec 29; 182(6):2625-30. PubMed ID: 19836779
    [Abstract] [Full Text] [Related]

  • 14. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Minato A, Noguchi H, Tomisaki I, Fukuda A, Kubo T, Nakayama T, Fujimoto N.
    Cancer Control; 2018 Dec 29; 25(1):1073274818800269. PubMed ID: 30213195
    [Abstract] [Full Text] [Related]

  • 15. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec 29; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 16. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory).
    Sözen S, Akbal C, Sökmensüer C, Ekici S, Ozen H.
    Urol Int; 2002 Dec 29; 69(3):200-6. PubMed ID: 12372888
    [Abstract] [Full Text] [Related]

  • 17. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
    Cai T, Tiscione D, Verze P, Pomara G, Racioppi M, Nesi G, Barbareschi M, Brausi M, Gacci M, Luciani LG, Liguori G, Gontero P, Campodonico F, Simonato A, Boddi V, Di Stasi SM, Colombo R, Serretta V, Carmignani G, Malossini G, Altieri V, Carini M, Terrone C, Bassi P, Montorsi F, Ficarra V, Selli C, Mirone V, Bartoletti R.
    Urology; 2014 Nov 29; 84(5):1141-6. PubMed ID: 25239253
    [Abstract] [Full Text] [Related]

  • 18. Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.
    Su JS, Arima K, Hasegawa M, Franco OE, Umeda Y, Yanagawa M, Sugimura Y, Kawamura J.
    Int J Urol; 2004 Feb 29; 11(2):74-82. PubMed ID: 14706010
    [Abstract] [Full Text] [Related]

  • 19. Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Jue JS, Koru-Sengul T, Moore KJ, Miao F, Alameddine M, Nahar B, Punnen S, Parekh DJ, Ritch CR, Gonzalgo ML.
    Can J Urol; 2018 Feb 29; 25(1):9179-9185. PubMed ID: 29524972
    [Abstract] [Full Text] [Related]

  • 20. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin.
    Brake M, Loertzer H, Horsch R, Keller H.
    J Urol; 2000 Jun 29; 163(6):1697-701. PubMed ID: 10799163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.